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a first-tier test for all pregnancies and stand-alone
test for specific clinical.
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Submicroscopic deletion of 9q34.3 is a genomic
rearrangement disorder that affects fetal development
and results in mental retardation and multiple congenital
anomalies. Heart defects are present in 40–45 % of
patients and include structural anomalies, namely atrial
septal defects, ventricular septal defects, valve anoma-
lies comprising pulmonary valve stenosis and bicuspid
aortic valve, persistent open foramen ovale and ductus
arteriosus anomalies. The subtelomeric deletion syn-
drome caused by this chromosome rearrangement is
one of the most common subtelomeric deletion syn-
dromes and some authors suggest that its phenotypic
features overlap with DiGeorge syndrome.
We report a prenatal diagnosis performed at
20+4 weeks gestation due to fetal cardiac defect and
absence of nasal bone. Molecular rapid aneuploidy test-
ing yielded normal results but DiGeorge/Velocardiofacial
Multiplex Ligation-dependent Probe Amplification
(MLPA) analysis revealed a deletion on 9q34.3 compris-
ing the EHMT1 gene, confirmed by fluorescence in situ
hybridization with a subtelomeric probe for 9q34.3. Cy-
togenetic analysis results were also consistent with a
terminal deletion. The couple opted for medical termina-
tion of pregnancy. Post-mortem examination of the 24-
weeks fetus revealed mild facial dysmorphism, bilateral
suprarenal hypoplasia and a complex cardiopathy show-
ing right implantation of truncus arteriosus, ventricular
septal defect, large right cavities and hypoplastic left
cavities. In order to establish a more accurate fetal
genotype-phenotype correlation, breakpoint mapping by
microarray is underway.
To our knowledge, this is the second case reported of
prenatally diagnosed 9q34.3 deletion and the first asso-
ciated with cardiac defects. This case reinforces the
importance of using MLPA methodology in fetuses
presenting with cardiopathy, since this approach allows
analysing all known low copy repeats at 22q11.2 and
several other regions associated with cardiac anomalies.
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The economic reasons combined with the improvement
of the non invasive markers for the screening of fetal
chromosomal anomalies has reduced the number of in-
vasive determinations in the majority of European
countries.
With the objective to reduce still more the costs,it has
suggested the option to combine echography and QF-
PCR without need to realise the conventional karyotype
in cases of numerical chromosome alteration suspicion.
In the last three years we had in our laboratory 621
cases (of a total of 12730 determinations) with chro-
mosomal alterations in amniotic fluid samples. All
these cases refered by echographic alterations and or
high risk in biochemical screening for Down’s
Sindrome.
Of the total of cases with chromosomal alterations,
497 were numerical and the rest of them were
structural.
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